ATE495271T1 - Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin - Google Patents
Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histaminInfo
- Publication number
- ATE495271T1 ATE495271T1 AT08786682T AT08786682T ATE495271T1 AT E495271 T1 ATE495271 T1 AT E495271T1 AT 08786682 T AT08786682 T AT 08786682T AT 08786682 T AT08786682 T AT 08786682T AT E495271 T1 ATE495271 T1 AT E495271T1
- Authority
- AT
- Austria
- Prior art keywords
- related disorders
- compositions
- methods
- detecting
- histamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07301286A EP2020446A1 (de) | 2007-07-31 | 2007-07-31 | Zusammensetzungen und Verfahren für den Nachweis von histaminbedingten Erkrankungen |
| PCT/EP2008/060057 WO2009016231A2 (en) | 2007-07-31 | 2008-07-31 | Compositions and methods for detecting histamine related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE495271T1 true ATE495271T1 (de) | 2011-01-15 |
Family
ID=38859059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08786682T ATE495271T1 (de) | 2007-07-31 | 2008-07-31 | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100297631A1 (de) |
| EP (2) | EP2020446A1 (de) |
| AT (1) | ATE495271T1 (de) |
| CA (1) | CA2695662A1 (de) |
| DE (1) | DE602008004556D1 (de) |
| WO (1) | WO2009016231A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12201676B2 (en) | 2011-03-18 | 2025-01-21 | Dr Healthcare España, S.L. | Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| ES2426539B1 (es) * | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
| US20230109016A1 (en) * | 2020-02-10 | 2023-04-06 | Immundiagnostik Ag | In-vitro diagnosis of histamine intolerance syndrome |
| EP4134672A1 (de) * | 2021-08-09 | 2023-02-15 | Immundiagnostik AG | Differentialdiagnose bei einem histaminintoleranzsyndroms |
| US20240219399A1 (en) * | 2021-08-10 | 2024-07-04 | Immundiagnostik Ag | Differential diagnosis of histamine intolerance syndrome |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010061A1 (en) * | 1989-03-02 | 1990-09-07 | Griffith University | Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals |
| WO1997022002A1 (de) * | 1995-12-08 | 1997-06-19 | Reimann Hans Juergen | Verfahren und vorrichtung zur in-vitro diagnose allergischer erkrankungen |
| US20050042630A1 (en) * | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| AT411688B (de) * | 2002-10-31 | 2004-04-26 | Jarisch Reinhard Dr | Verfahren zur bestimmung der aktivität von diaminooxidase |
| US7772011B2 (en) * | 2005-03-21 | 2010-08-10 | Ronald Joseph Harbeck | Method and kit for detection of autoimmune chronic urticaria |
| AT502850B1 (de) * | 2005-11-18 | 2007-08-15 | Albert Dr Missbichler | Verfahren zur bestimmung der aktivität von diaminooxidase |
-
2007
- 2007-07-31 EP EP07301286A patent/EP2020446A1/de not_active Withdrawn
-
2008
- 2008-07-31 AT AT08786682T patent/ATE495271T1/de not_active IP Right Cessation
- 2008-07-31 US US12/671,285 patent/US20100297631A1/en not_active Abandoned
- 2008-07-31 CA CA2695662A patent/CA2695662A1/en not_active Abandoned
- 2008-07-31 DE DE602008004556T patent/DE602008004556D1/de active Active
- 2008-07-31 WO PCT/EP2008/060057 patent/WO2009016231A2/en not_active Ceased
- 2008-07-31 EP EP08786682A patent/EP2183389B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| DE602008004556D1 (de) | 2011-02-24 |
| EP2183389B1 (de) | 2011-01-12 |
| WO2009016231A2 (en) | 2009-02-05 |
| WO2009016231A3 (en) | 2009-04-09 |
| US20100297631A1 (en) | 2010-11-25 |
| CA2695662A1 (en) | 2009-02-05 |
| EP2020446A1 (de) | 2009-02-04 |
| EP2183389A2 (de) | 2010-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0421639D0 (en) | Methods and compositions relating to alzheimer's disease | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| CY1118660T1 (el) | Συνθεσεις και μεθοδοι για την θεραπεια διαταραχων ματιων | |
| WO2008042231A3 (en) | Compositions and methods for evaluating and treating heart failure | |
| MY164376A (en) | Phosphospecific antibodies recognizing tau | |
| WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
| BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| MX2009004705A (es) | Moleculas de enlace de albumina y usos de las mismas. | |
| MX385354B (es) | Sales de xantilio 3,6-disustituidas. | |
| ATE485517T1 (de) | Verfahren zur identifizierung von polypeptid- targets | |
| DK1915620T3 (da) | Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer | |
| WO2006063093A3 (en) | Methods for diagnosis and treatment of crohn's disease | |
| ATE495271T1 (de) | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin | |
| EA200800667A1 (ru) | Аптамеры, связывающие тромбин с высокой аффинностью | |
| CY1113310T1 (el) | Εξανθρωπισμενα αντισωματα ειδικα για nogo-a και φαρμακευτικες χρησεις αυτων | |
| WO2008112840A3 (en) | Novel composition and methods for the treatment of immune related diseases | |
| TW200716172A (en) | Pharmaceutical compositions for treating lower motor neuron diseases | |
| WO2007059064A3 (en) | Fgf2-related methods for diagnosing and treating depression | |
| MY150098A (en) | Benzylpiperazine derivates and their medical use | |
| WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
| ATE407126T1 (de) | Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on | |
| ATE552503T1 (de) | Ctgf als biomarker, therapeutisches und diagnostisches ziel | |
| ATE544856T1 (de) | Peptid- und nukleotidsequenzen von anisakis spp. und ihre verwendung | |
| CL2008003232A1 (es) | Compuestos derivados de bencensulfonanilida; composición farmacéutica que los comprende; y uso en el tratamiento de enfermedades del sistema nervioso central, disfunciones cognitivas, esquizofrenia, enfermedades adictivas, enfermedad de alzheimer u obesidad. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |